Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 21 | 6 | 21 | 159 | 66 |
| Inventories | N/A | N/A | 0 | 0 | 2 |
| TOTAL | $25 | $6 | $21 | $159 | $69 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | N/A | N/A | 1 |
| TOTAL | $0 | $0 | $0 | $0 | $1 |
| Total Assets | $25 | $6 | $21 | $159 | $70 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 20 | 20 | 89 | 119 | 155 |
| Accounts payable and accrued liabilities | 428 | 402 | 334 | 198 | 377 |
| Accrued Expenses | 228 | 224 | 226 | 226 | 227 |
| TOTAL | $922 | $732 | $649 | $543 | $759 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $922 | $732 | $649 | $543 | $759 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 600,375 | 600,375 | 546,496 | 475,639 | 466,374 |
| Common Shares | 600 | 562 | 477 | 476 | 456 |
| Retained earnings | -17,350 | -17,017 | -12,754 | -8,236 | -7,340 |
| Other shareholders' equity | 0 | 500 | 812 | 812 | 0 |
| TOTAL | $-897 | $-726 | $-629 | $-384 | $-689 |
| Total Liabilities And Equity | $25 | $6 | $20 | $159 | $70 |